Premium
CD19/CD20‐REDIRECTED BISPECIFIC CAR T CELL TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA
Author(s) -
Wang Y.,
Wu Z.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.116_2630
Subject(s) - medicine , cd20 , lymphoma , cd19 , non hodgkin's lymphoma , refractory (planetary science) , oncology , common terminology criteria for adverse events , adverse effect , immunology , antigen , biology , astrobiology